{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:44:20Z","timestamp":1790905460542,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.bbrc.2006.07.057","type":"journal-article","created":{"date-parts":[[2006,7,22]],"date-time":"2006-07-22T11:16:01Z","timestamp":1153566961000},"page":"70-75","source":"Crossref","is-referenced-by-count":50,"title":["Aldosterone promotes fibronectin production through a Smad2-dependent TGF-\u03b21 pathway in mesangial cells"],"prefix":"10.1016","volume":"348","author":[{"given":"Lingyun","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Ming","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2006.07.057_bib1","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.273.9.4883","article-title":"Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation","volume":"273","author":"Silvestre","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2006.07.057_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s000590050024","article-title":"Aldosterone and myocardial fibrosis in heart failure","volume":"25","author":"Brilla","year":"2000","journal-title":"Herz"},{"key":"10.1016\/j.bbrc.2006.07.057_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2006.07.057_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.mnh.0000165889.60254.98","article-title":"Aldosterone and end-organ damage","volume":"14","author":"Brown","year":"2005","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbrc.2006.07.057_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00701.x","article-title":"Aldosterone in the development and progression of renal injury","volume":"66","author":"Hollenberg","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2006.07.057_bib6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2006.07.057_bib7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.33.1.232","article-title":"Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats","volume":"33","author":"Rocha","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2006.07.057_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJM200109203451215","article-title":"Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease","volume":"345","author":"Chrysostomou","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2006.07.057_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.0000044937.95080.E9","article-title":"Effectiveness of aldosterone blockade in patients with diabetic nephropathy","volume":"41","author":"Sato","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2006.07.057_bib10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2006.07.057_bib11","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group","volume":"329","author":"Lewis","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2006.07.057_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2006.07.057_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/exmp.1993.1040","article-title":"The effect of transforming growth factor \u03b21 on mesangial cell fibronectin synthesis: increased incorporation into the extracellular matrix and reduced pI but no effect on alternative splicing","volume":"59","author":"McKay","year":"1993","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbrc.2006.07.057_bib14","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1172\/JCI112734","article-title":"Angiotensin II and vasopressin stimulate calcium-activated chloride conductance in rat mesangial cells","volume":"78","author":"Okuda","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2006.07.057_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1677\/joe.0.1650533","article-title":"Aldosterone mediates angiotensin II-stimulated rat vascular smooth muscle cell proliferation","volume":"165","author":"Xiao","year":"2000","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbrc.2006.07.057_bib16","first-page":"F781","article-title":"Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron","volume":"264","author":"Todd-Turla","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2006.07.057_bib17","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1210\/endo.136.9.7649078","article-title":"Cloning, expression, and tissue distribution of the rat nicotinamide adenine dinucleotide-dependent 11 \u03b2-hydroxysteroid dehydrogenase","volume":"136","author":"Zhou","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2006.07.057_bib18","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/j.1523-1755.2004.66004.x","article-title":"AGEs activate mesangial TGF-\u03b2-Smad signaling via an angiotensin II type I receptor interaction","volume":"66","author":"Fukami","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2006.07.057_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","article-title":"Clinical characteristics of primary aldosteronism from an analysis of 145 cases","volume":"107","author":"Conn","year":"1964","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.bbrc.2006.07.057_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ki.1982.14","article-title":"Plasma aldosterone concentrations in chronic renal disease","volume":"21","author":"Hene","year":"1982","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2006.07.057_bib21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1006\/jmcc.1999.0963","article-title":"Extra-adrenal mineralocorticoids and cardiovascular tissue","volume":"31","author":"Slight","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2006.07.057_bib22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily","volume":"240","author":"Evans","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2006.07.057_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.med.48.1.231","article-title":"Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance","volume":"48","author":"Funder","year":"1997","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbrc.2006.07.057_bib24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1046\/j.1523-1755.2000.00959.x","article-title":"Specificity in mineralocorticoid versus glucocorticoid action","volume":"57","author":"Fuller","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2006.07.057_bib25","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/j.1523-1755.2005.00263.x","article-title":"Aldosterone makes human endothelium stiff and vulnerable","volume":"67","author":"Oberleithner","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2006.07.057_bib26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cardiores.2003.11.037","article-title":"Review of aldosterone- and angiotensin II-induced target organ damage and prevention","volume":"61","author":"Struthers","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2006.07.057_bib27","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2006.07.057_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.CIR.92.2.175","article-title":"Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 \u03b2-hydroxysteroid dehydrogenase in the human heart","volume":"92","author":"Lombes","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2006.07.057_bib29","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1046\/j.1523-1755.2000.00973.x","article-title":"Cardiac aldosterone production and ventricular remodeling","volume":"57","author":"Delcayre","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2006.07.057_bib30","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1172\/JCI117251","article-title":"Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-\u03b2 expression in rat glomerular mesangial cells","volume":"93","author":"Kagami","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2006.07.057_bib31","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1046\/j.1523-1755.1998.00164.x","article-title":"Targeting TGF-\u03b2overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade","volume":"54","author":"Peters","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2006.07.057_bib32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/ki.1996.372","article-title":"Insulin and angiotensin II are additive in stimulating TGF-\u03b21 and matrix mRNAs in mesangial cells","volume":"50","author":"Anderson","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2006.07.057_bib33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1523-1755.2002.00537.x","article-title":"Involvement of HB-EGF and EGF receptor transactivation in TGF-\u03b2-mediated fibronectin expression in mesangial cells","volume":"62","author":"Uchiyama-Tanaka","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2006.07.057_bib34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/diabetes.53.1.200","article-title":"Peroxisome proliferator-activated receptor-\u03b3 ligands inhibit TGF-\u03b2 1-induced fibronectin expression in glomerular mesangial cells","volume":"53","author":"Guo","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2006.07.057_bib35","doi-asserted-by":"crossref","first-page":"F1059","DOI":"10.1152\/ajprenal.00202.2003","article-title":"Effect of aldosterone on renal transforming growth factor-\u03b2","volume":"286","author":"Juknevicius","year":"2004","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.bbrc.2006.07.057_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2003.09.026","article-title":"Corticosteroids stimulate selectively transforming growth factor (TGF)-\u03b2receptor type III expression in transdifferentiating hepatic stellate cells","volume":"40","author":"Wickert","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2006.07.057_bib37","first-page":"S115","article-title":"Aldosterone is a major factor in the progression of renal disease","volume":"63","author":"Ibrahim","year":"1997","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.bbrc.2006.07.057_bib38","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/01.HYP.35.5.1078","article-title":"Local angiotensin II and transforming growth factor-\u03b21 in renal fibrosis of rats","volume":"35","author":"Sun","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2006.07.057_bib39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/37284","article-title":"TGF-\u03b2signalling from cell membrane to nucleus through SMAD proteins","volume":"390","author":"Heldin","year":"1997","journal-title":"Nature"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X06015257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X06015257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T06:24:57Z","timestamp":1555741497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X06015257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0006291X06015257"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2006.07.057","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}